Linagliptin for elderly patients with type 2 diabetes - Authors' reply.
Diabetes Centre, Heart of England NHS Foundation Trust, and University of Birmingham, Birmingham, B9 5SS, UK. Electronic address: anthony.barnett@heartofengland.nhs.uk.
Anthony H
AH
Barnett
Boehringer Ingelheim, Ingelheim, Germany.
Maximilian
M
von Eynatten
Boehringer Ingelheim, Bracknell, UK.
Sanjay
S
Patel
Boehringer Ingelheim, Ingelheim, Germany.
Hans-Juergen
HJ
Woerle
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D011687:Purines / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*
D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; D011687:Purines; D011799:Quinazolines